Zouhir Gadi

Antwerpen, VLG, Belgium

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Steatotic liver disease trajectory: A holistic EASL guidance on the multidisciplinary approach to screening and patient management.

Steatotic liver disease trajectory: A holistic EASL guidance on the multidisciplinary approach to screening and patient management.

Journal: JHEP reports : innovation in hepatology

Published: January 20, 2026

Diagnostic Accuracy of Noninvasive Tests for Metabolic Dysfunction-associated Steatotic Liver Disease Across Age, Type 2 Diabetes, and Obesity Subgroups: A Multinational Study.

Diagnostic Accuracy of Noninvasive Tests for Metabolic Dysfunction-associated Steatotic Liver Disease Across Age, Type 2 Diabetes, and Obesity Subgroups: A Multinational Study.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: November 01, 2025

Diagnostic Accuracy of Noninvasive Tests for Metabolic Dysfunction-Associated Steatotic Liver Disease Across Age, Type 2 Diabetes, and Obesity Subgroups: A Multinational Study.

Diagnostic Accuracy of Noninvasive Tests for Metabolic Dysfunction-Associated Steatotic Liver Disease Across Age, Type 2 Diabetes, and Obesity Subgroups: A Multinational Study.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: November 01, 2025

Diagnostic Accuracy of Non-Invasive Tests for MASLD Across Age, Type 2 Diabetes, and Obesity Subgroups: A Multinational Study.

Diagnostic Accuracy of Non-Invasive Tests for MASLD Across Age, Type 2 Diabetes, and Obesity Subgroups: A Multinational Study.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: November 01, 2025

Predictors of fibrosis, clinical events, and mortality in MASLD: Data from the Global-MASLD study.

Predictors of fibrosis, clinical events, and mortality in MASLD: Data from the Global-MASLD study.

Journal: Hepatology (Baltimore, Md.)

Published: August 21, 2025

Predictors of fibrosis, clinical events and mortality in MASLD: Data from the Global-MASLD study.

Predictors of fibrosis, clinical events and mortality in MASLD: Data from the Global-MASLD study.

Journal: Hepatology (Baltimore, Md.)

Published: August 21, 2025

Global performance of non-invasive tests in MASLD: Insights from the G-MASLD study.

Global performance of non-invasive tests in MASLD: Insights from the G-MASLD study.

Journal: Hepatology (Baltimore, Md.)

Published: July 11, 2025

MASH to cirrhosis: bridging the gaps in MASLD management.

MASH to cirrhosis: bridging the gaps in MASLD management.

Journal: Acta clinica Belgica

Published: February 25, 2025

Metabolic Dysfunction-Associated Fibrosis 5 (MAF-5) Score Predicts Liver Fibrosis Risk and Outcome in the General Population With Metabolic Dysfunction.

Metabolic Dysfunction-Associated Fibrosis 5 (MAF-5) Score Predicts Liver Fibrosis Risk and Outcome in the General Population With Metabolic Dysfunction.

Journal: Gastroenterology

Published: October 17, 2023

Showing 1-9 of 9

Last Updated: 09/26/2026